Open $212.30
Day Range 212.01 - 221.50
52 Week Range 54.21 - 227.71
Market Cap $85.53B
Shares Outstanding 401.53M
Public Float 341.89M
Beta 0.29
Rev. per Employee $618.00K
P/E Ratio 173.40
EPS $1.25
Yield N/A
Dividend N/A
Ex-Dividend Date N/A
Short Interest 11.83M 05/28/21
% of Float Shorted 3.46%
Average Volume 9.27M

5 Day	11.38%
1 Month	45.09%
3 Month	54.79%
YTD	108.14%
1 Year	261.20%

Sell
Under
Hold
Over
Buy

Number of Ratings 18 Full Ratings

MarketWatch
Dow Jones

Moderna files for its COVID-19 vaccine to be granted emergency use in adolescents

Jun. 10, 2021 at 8:14 a.m. ET by Tomi Kilgore

Moderna Requests U.S. Emergency-Use Authorization for Covid-19 Vaccine in Adolescents

Jun. 10, 2021 at 8:28 a.m. ET

Moderna files for EUA for COVID-19 vaccine in adolescents

Jun. 10, 2021 at 8:02 a.m. ET by Tomi Kilgore

Moderna Inc. stock rises Wednesday, outperforms market

Jun. 9, 2021 at 4:31 p.m. ET by MarketWatch Automation

New daily COVID-19 cases and deaths rise again as concerns over delta variant and Biden vaccination target for July 4 increase

Jun. 9, 2021 at 12:21 p.m. ET by Tomi Kilgore

Moderna Inc. stock underperforms Tuesday when compared to competitors

Jun. 8, 2021 at 4:31 p.m. ET by MarketWatch Automation

New U.S. COVID-19 cases and deaths tick higher, while CDC’s ‘real world’ study shows Pfizer, Moderna vaccines reduce infection risk by 91%

Jun. 8, 2021 at 11:43 a.m. ET by Tomi Kilgore

Moderna Inc. stock rises Monday, outperforms market

Jun. 7, 2021 at 4:31 p.m. ET by MarketWatch Automation

Moderna Shares Up 8% After Adolescents Covid-19 Filings in EU and Canada

Jun. 7, 2021 at 1:21 p.m. ET

Moderna and Medison Pharma to Commercialize Covid-19 Vaccine in Central Eastern Europe, Israel

Jun. 7, 2021 at 8:51 a.m. ET

Moderna Seeks Conditional Marketing Approval for Covid-19 Vaccine in Adolescents in EU

Jun. 7, 2021 at 8:09 a.m. ET

Moderna submits for marketing approval of COVID-19 vaccine in adolescents in Europe

Jun. 7, 2021 at 7:51 a.m. ET by Tomi Kilgore

Moderna submitted for a CMA for its COVID-19 vaccine in adolescents with EMA

Jun. 7, 2021 at 7:42 a.m. ET by Tomi Kilgore

Here’s what AMC Entertainment’s monster stock surge ‘memes’ for ETFs

Jun. 3, 2021 at 11:51 a.m. ET by Mark DeCambre

Barron's

The Top-Returning IPOs of the Pandemic

Jun. 4, 2021 at 8:41 p.m. ET by Barron's

Moderna Inc. stock rises Friday, outperforms market

Jun. 4, 2021 at 4:31 p.m. ET by MarketWatch Automation

Barron's

The Dangerous Politicization of American Science

Jun. 4, 2021 at 12:11 p.m. ET by Barron's

Global COVID-19 cases top 172 million as WHO warns of possible third wave in Africa after 20% increase in infections in two weeks

Jun. 4, 2021 at 9:58 a.m. ET by Ciara Linnane

Moderna Inc. stock outperforms competitors on strong trading day

Jun. 3, 2021 at 4:31 p.m. ET by MarketWatch Automation

Covax gets $2.4 billion in COVID vaccine supply commitments for world’s poorest countries as experts warn on variants

Jun. 3, 2021 at 10:35 a.m. ET by Ciara Linnane

No Headlines Available

Other News
Press Releases

How Does Moderna Measure up to Bigger Rival Pfizer?

Jun. 10, 2021 at 6:30 a.m. ET on Motley Fool

This Is What Will Drive Moderna's Growth Over the Next Decade

Jun. 10, 2021 at 6:00 a.m. ET on Motley Fool

Could Ocugen Be a Millionaire-Maker Stock?

Jun. 9, 2021 at 7:23 a.m. ET on Motley Fool

Here's Why 2022 May Be Even Bigger for Moderna Than 2021

Jun. 9, 2021 at 6:45 a.m. ET on Motley Fool

The Zacks Analyst Blog Highlights: Amazon, Tesla, UnitedHealth Group, T-Mobile and Moderna

Jun. 9, 2021 at 6:44 a.m. ET on Zacks.com

Will Moderna's Next Earnings Report Top Its Billion-Dollar First Quarter?

Jun. 9, 2021 at 6:30 a.m. ET on Motley Fool

Is First Trust Multi Cap Growth AlphaDEX ETF (FAD) a Strong ETF Right Now?

Jun. 9, 2021 at 6:20 a.m. ET on Zacks.com

Is Moderna Stock Overvalued -- or a Bargain?

Jun. 9, 2021 at 6:00 a.m. ET on Motley Fool

Why Pfizer and Moderna Could Soon Be Big Winners in a New $22 Billion Market

Jun. 9, 2021 at 5:52 a.m. ET on Motley Fool

There’s Good Reason to Believe Novavax Will Rise Soon

Jun. 8, 2021 at 1:44 p.m. ET on InvestorPlace.com

Top Research Reports for Amazon, Tesla & UnitedHealth

Jun. 8, 2021 at 1:16 p.m. ET on Zacks.com

5 Healthcare Stocks to Buy for Their Game-Changing Potential

Jun. 8, 2021 at 11:37 a.m. ET on InvestorPlace.com

This 1 Big Element May Push Moderna Ahead of Pfizer

Jun. 8, 2021 at 11:00 a.m. ET on Motley Fool

Moderna (MRNA) Seeks Approval for COVID-19 Vaccine in Teens

Jun. 8, 2021 at 10:23 a.m. ET on Zacks.com

Is a Potential Patent Waiver Bad News for Moderna?

Jun. 8, 2021 at 9:45 a.m. ET on Motley Fool

Moderna Inks Deal with Medison Pharma; Shares Up 6.6%

Jun. 8, 2021 at 9:44 a.m. ET on TipRanks.com

Stock Market News for Jun 8, 2021

Jun. 8, 2021 at 9:30 a.m. ET on Zacks.com

3 Tips for COVID Vaccine Stock Investing Right Now

Jun. 8, 2021 at 6:00 a.m. ET on Motley Fool

Why Moderna Stock Popped Today

Jun. 7, 2021 at 5:47 p.m. ET on Motley Fool

These Vaccine Latecomers Could Still Win Big. Here's How

Jun. 7, 2021 at 3:13 p.m. ET on Motley Fool

No Headlines Available

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA). Its product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rose and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.